Skip to content

Efficacy and safety of mouthwash and oral tablet of propolis on the mucositis in hematopoietic stem cell transplantation recipients

Evaluation of efficacy of mouthwash and oral tablet of propolis on prevention and treatment of mucositis in hematopoietic stem cell transplantation recipients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100127003210N24
Enrollment
84
Registered
2021-11-11
Start date
2021-11-15
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Oral mucositis. Condition 2: Gastrointestinal mucositis. Oral mucositis (ulcerative) due to antineoplastic therapy Gastrointestinal mucositis (ulcerative)

Interventions

Intervention 1: Intervention group: receiving propolis, in amounts of 7.5 ml, from the mouthwash form, every 12 hours, for 15 days and one tablet, from the oral form, every 8 hours, for 10 days, along

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients hospitalized in bone marrow transplantation who received conditioning chemotherapy regimen Patient satisfaction and cooperation to participate in the study Ability to communicate and answering questions during the period of mucositis Patients from previous chemotherapy or radiotherapy should not have oral mucositis and should be included in the study from the beginning of treatment

Exclusion criteria

Exclusion criteria: History of allergies to propolis or other components of mouthwash and oral tablet History of asthma, seasonal allergies and history of aspirin allergy Taking anticoagulant drugs such as warfarin Fasting blood sugar above 150 mg/dl

Design outcomes

Primary

MeasureTime frame
Mucositis. Timepoint: First day of chemotherapy until engraftment day. Method of measurement: WHO scoring system.

Secondary

MeasureTime frame
Fever grade. Timepoint: From the first day of chemotherapy until engraftment time. Method of measurement: Submit a fever above 38.3 °C for patients.;The need for total parenteral nutrition (TPN). Timepoint: During the study period. Method of measurement: Sign the days of parenteral nutrition intake.;The amount of narcotics analgesics needed. Timepoint: Daily. Method of measurement: Patient's medication list.;The amount of antibiotics needed. Timepoint: Daily. Method of measurement: Patient's medication list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Khanzadeh

Shahid Beheshti University of Medical Sciences

Khnzd1996@gmail.com+98 21 8820 0118

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026